|
|
At 4-year
|
follow-up
|
|
|
|
Metabolic syndrome -
|
Metabolic syndrome +
|
P
|
|
N
|
505
|
107
|
|
|
Age, y
|
50.9 (6.6)
|
52.7 (6.1)
|
0.005*
|
|
Cardiovascular disease,%
|
29
|
44
|
0.001
|
|
Smokers,%
|
33
|
31
|
0.70
|
|
Blood pressure medication,%
|
11
|
31
|
<0.001
|
|
Systolic blood pressure, mmHg
|
128.8 (14.0)
|
135.3 (15.6)
|
<0.001
|
|
Diastolic blood pressure, mmHg
|
85.6 (9.7)
|
90.6 (8.9)
|
<0.001
|
|
BMI, kg·m-2
|
25.5 (3.2)
|
28.0 (4.4)
|
<0.001
|
|
Waist-to-hip ratio
|
0.92 (0.06)
|
0.96 (0.05)
|
<0.001
|
|
Serum HDL cholesterol, mmol·l-1
|
1.36 (0.30)
|
1.23 (0.26)
|
<0.001
|
|
Serum triglycerides, mmol·l-1
|
1.14 (0.56)
|
1.48 (0.96)
|
<0.001
|
|
Fasting blood glucose, mmol·l-1
|
4.4 (0.4)
|
4.6 (0.4)
|
0.002
|
|
Fasting serum insulin,
pmol·L-1
|
56.3 (18.1)
|
73.6 (22.9)
|
<0.001
|
|
VO2max†, ml·kg-1·min-1
|
33.6 (7.9)
|
28.5 (7.2)
|
<0.001
|
|
Total ‡LTPA, min·wk-1
|
393 (231 – 618)
|
320 (164 – 501)
|
0.006
|
|
LTPA <4.5 METs§,
min·wk-1
|
195 (84 – 370)
|
143 (58 – 303)
|
0.032
|
|
LTPA ³ 4.5
METs, min·wk-1
|
147 (63 – 255)
|
121 (43 – 211)
|
0.030
|
|
LTPA ³ 7.5
METs, min·wk-1
|
31 (7 – 91)
|
12 (0 – 42)
|
<0.001
|
Values are means (SD) except for LTPA variables, which
are presented as medians and interquartile ranges. *Mann-Whitney
U-test.
†VO2max, maximal oxygen uptake.
‡LTPA, leisure-time physical activity.
§METs, metabolic equivalents.
|